RT @jitcancer: New #JITC review: Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for…

📢 Excited to share our @sitcancer review: "Advances in the understanding and therapeutic manipulation of cancer immune responsiveness"! Grateful to Francesco Marincola and @MarcoRuella for the opportunity to contribute!

Grateful to #ASH2024 for the chance to present our work on overcoming the absence of CD2:CD58 co-stimulation using an innovative PD1:iCD2 switch receptor. Thanks to my mentor @MarcoRuella and the @RuellaLab for their invaluable support. Excited to delve deeper into this approach!

Overcoming the Lack of CD2:CD58 Costimulation in Chimeric Antigen Receptor T-Cell Immunotherapies 1/504/530305/Overcoming-the-Lack-of-CD2-CD58-Costimulation-in #ASH2024